CNSX:HUGE FSD Pharma (HUGE) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free HUGE Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume4,870 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get FSD Pharma alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About FSD Pharma Stock (CNSX:HUGE)FSD Pharma Inc. operates as a cannabis company in Canada. It is involved in hydroponic indoor cannabis production and processing activities. The company, through its subsidiary, FV Pharma Inc., holds license to produce marijuana under the Access to Cannabis for Medical Purposes Regulations. It has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products developed by SciCann Therapeutics Inc. The company was formerly known as Century Financial Capital Group Inc. and changed its name to FSD Pharma Inc. in May 2018. FSD Pharma Inc. was incorporated in 1994 and is headquartered in Cobourg, Canada.Read More Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… HUGE Stock News HeadlinesMarch 16, 2024 | finance.yahoo.comHUGE Apr 2024 2.000 putFebruary 28, 2024 | finanznachrichten.deFSD Pharma Inc.: FSD Pharma Announces Debt SettlementMarch 29, 2024 | Crypto 101 Media (Ad)Top Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.February 26, 2024 | msn.comBiotech Company Develops Inebriation Remedy Beverage 'UNBUZZD'November 7, 2023 | finance.yahoo.comFSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One BasisSeptember 18, 2023 | finance.yahoo.comFSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well ToleratedAugust 15, 2023 | finance.yahoo.comFSD Pharma Selected to Present its Phase 1 Data on Lucid-MS at MSMilan 2023 – 9th Joint ECTRIMS-ACTRIMS Meeting for October 11-13, 2023August 3, 2023 | finance.yahoo.comInvestmentPitch Media Video Features FSD Pharma’s Definitive Agreement Granting Exclusive Rights for Launch of UNBUZZD, a Revolutionary Rapid Alcohol Detoxification DrinkMarch 29, 2024 | Crypto 101 Media (Ad)Top Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.June 23, 2023 | finance.yahoo.comInvestmentPitch Media Video Discusses FSD Pharma’s Granting of Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology to Celly NutritionJune 20, 2023 | msn.comFSD Pharma Announces Agreement To Grant Exclusive Rights To Recreational Alcohol Misuse TechnologyJune 20, 2023 | finance.yahoo.comFSD Pharma Announces Agreement to Grant Exclusive Rights to Revolutionary Recreational Alcohol Misuse TechnologyMay 25, 2023 | finance.yahoo.comFSD Pharma Appoints Former Ontario Minister of Health Doctor Eric Hoskins to Board of DirectorsMay 13, 2023 | finance.yahoo.comFSD Pharma Inc. (HUGE.CN)May 11, 2023 | finance.yahoo.comFSD Pharma Awarded $2.81 Million in Cost Awards From Dr. Raza BokhariMay 10, 2023 | msn.comPromising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing CompletedMay 10, 2023 | finance.yahoo.comFSD Pharma Completes Dosing of First Cohort in Phase I Clinical Trial of Lucid-MS, a New Drug Candidate for the Treatment of Multiple Sclerosis: Safety Review Committee Recommends Commencing Dosing of Second CohortApril 19, 2023 | benzinga.comDynamic Duo of Celsius Holdings Fame join FSD Pharma calling Medical Product under Development "Unique and Disruptive"April 12, 2023 | finance.yahoo.comFSD Pharma Announces Plan to Spin-Out Subsidiary as Distribution to Shareholders; Shareholder Meeting Scheduled for June 29, 2023April 12, 2023 | finance.yahoo.comIIROC Trading Halt - HUGEApril 12, 2023 | finance.yahoo.comIIROC Trade Resumption - HUGEFebruary 21, 2023 | finance.yahoo.comFSD Pharma Presenting Two Scientific Posters on Preclinical Toxicology and Efficacy Data of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2023 ForumFebruary 15, 2023 | finance.yahoo.comFSD Pharma Regains Compliance with NASDAQ Continued Listing RequirementsFebruary 7, 2023 | proactiveinvestors.comFSD Pharma receives regulatory clearance for proposed Phase 1 clinical trial of multiple sclerosis drug candidate Lucid-MSJanuary 17, 2023 | proactiveinvestors.comFSD Pharma submits clinical trial application for its multiple sclerosis treatment candidate Lucid-MSJanuary 17, 2023 | finance.yahoo.comFSD Pharma submits its phase-1 Clinical Trial Application for Lucid-MS (Lucid-21-302) for first-in-human safety and tolerability investigationJanuary 9, 2023 | msn.comTesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On MondaySee More Headlines Receive HUGE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for FSD Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorComputer and Technology Industry Software - Application Sub-IndustryN/A Current SymbolCNSX:HUGE CUSIPN/A CIKN/A WebN/A PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key Competitors1mage SoftwareCNSX:ISOLBlox LabsCNSX:BLOXFandom Sports MediaCNSX:FDMHelmerich & PayneCNSX:HPiShares U.S. Digital Infrastructure and Real Estate ETFCNSX:IGNView All CompetitorsInsidersZeeshan SaeedBought 23,000 shares on 4/13/2023Total: $57,960.00 ($2.52/share) HUGE Stock Analysis - Frequently Asked Questions What other stocks do shareholders of FSD Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other FSD Pharma investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Cannara Biotech (LOVE), Aphria (APHA), Bombardier, Inc. Class B (BBD.B), Costco Wholesale (COST) and Enbridge (ENB). How do I buy shares of FSD Pharma? Shares of HUGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:HUGE) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FSD Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.